Happy 2022 and everything goes well

News 2021.12.317745

Related News

First in China! Neuboron’s BNCT Drug-Device Product Phase I Registration Clinical Trial Launched at Xiamen Humanity Hospital

2024.04.24
Neuboron: Independently Developed Integrated BNCT Drug-Device Solution Debuts at CSTRO

2024.11.19
Neuboron Medtech, a BNCT total solution provider, enters Joint-Venture Agreement with TAE Life Sciences, further consolidating Neuboron’s global influence

2020.12.09
Rainer Gunzelmann, Partner of Wuesthoff & Wuesthoff，presides as the honorary international chief IP consultant of Neuboron Medtech since 2021

2021.03.19